Torthaí cuardaigh údar :: APM

1

Emerging potential benefits of modulating NAD<sup>+</sup>metabolism in cardiovascular disease de réir Daniel S. Matasic, Charles Brenner, Barry London

Foilsithe / Cruthaithe 2017

Faigh an téacs iomlán Faigh an téacs iomlán
Revisão

Cuir le mo chuid Ceanán

Sábháilte in:
2

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention de réir Arielle Abovich, Daniel S. Matasic, Rhanderson Cardoso, Chiadi E. Ndumele, Roger S. Blumenthal, Ron Blankstein, Martha Gulati

Foilsithe / Cruthaithe 2023

Faigh an téacs iomlán
Revisão

Cuir le mo chuid Ceanán

Sábháilte in:
3

Cardiac <i>Stim1</i> Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling de réir Ludovic Bénard, Jae Gyun Oh, Marine Cacheux, Ah Young Lee, Mathieu Nonnenmacher, Daniel S. Matasic, Erik Kohlbrenner, Changwon Kho, Catherine Pavoine, Roger J. Hajjar, Jean‐Sébastien Hulot

Foilsithe / Cruthaithe 2016

Faigh an téacs iomlán Faigh an téacs iomlán
Artigo

Cuir le mo chuid Ceanán

Sábháilte in:
4

Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channel de réir Ajit Vikram, Christopher Lewarchik, Jin‐Young Yoon, Asma Naqvi, Santosh Kumar, Gina Morgan, Julia S. Jacobs, Qiuxia Li, Young‐Rae Kim, Modar Kassan, Jing Liu, Mohanad Gabani, Ajay Kumar, Haider Mehdi, Xiaodong Zhu, Xiaoqun Guan, William Kutschke, Xiaoming Zhang, Ryan L. Boudreau, Shengchuan Dai, Daniel S. Matasic, Saet-Byel Jung, Kenneth B. Margulies, Vikas Kumar, Markus Bachschmid, Barry London, Kaikobad Irani

Foilsithe / Cruthaithe 2017

Faigh an téacs iomlán
Artigo

Cuir le mo chuid Ceanán

Sábháilte in: